Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines.
Clinical trial NCT07622004 · COMPLETED
Trial details
- NCT number
- NCT07622004
- Sponsor
- INIBIO Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2022-01-30
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.